La Palma, CA, United States of America

Christopher Jen-Yue Wei

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Christopher Jen-Yue Wei

Introduction

Christopher Jen-Yue Wei is a prominent inventor based in La Palma, California, known for his contributions to the field of genetics and biotechnology. With a total of two patents to his name, Wei has made significant strides in developing methods that enhance sequencing technologies, particularly relevant in the age of precision medicine and genomics.

Latest Patents

Wei's latest patents focus on "Polynucleotide Barcodes for Long Read Sequencing." These innovations provide methods for making, amplifying, and sequencing tagged nucleic acid complements. The work includes compositions that feature interposing oligonucleotide barcodes and kits designed to facilitate the acquisition of long-range sequence data. These advancements are pivotal in improving the accuracy and efficiency of genomic sequencing.

Career Highlights

Currently, Christopher Jen-Yue Wei is associated with Singular Genomics Systems, Inc., where he applies his expertise to enhance genetic research and product development. His contributions have positioned him as a valuable asset within the industry, helping to usher in new technologies that facilitate more effective research outcomes in genomics.

Collaborations

Throughout his career, Wei has collaborated with esteemed colleagues like Eli N. Glezer and Martin Maria Fabani. These partnerships exemplify the collaborative spirit that drives innovation in the scientific community and further underscores Wei's commitment to advancement in his field.

Conclusion

Christopher Jen-Yue Wei represents a beacon of innovation in biotechnology, with his pioneering patents demonstrating tangible advancements in the capability of long-read sequencing. As he continues to work with Singular Genomics Systems, Inc., his role in shaping the future of genetic research remains significant, reflecting the fruitful potential of his inventive contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…